The Difference Between Throat Cancer and Esophageal Cancer

Written by Li Rui
Otolaryngology
Updated on September 10, 2024
00:00
00:00

Throat cancer and esophageal cancer have essential differences, starting with the specific location of the disease. Throat cancer primarily occurs in the glottis and the supraglottic area, while esophageal cancer mainly occurs in the esophagus. Typically, the symptoms of throat cancer may be more characteristic, the most common being a foreign body sensation in the throat, throat pain, and hoarseness. Particularly, glottic throat cancer symptoms are more pronounced, which might include persistent and noticeable hoarseness. The primary symptoms of esophageal cancer are pain below the neck, which may be accompanied by difficulty swallowing or swallowing obstruction. For diagnosis, throat cancer is primarily assessed via laryngoscopy, while esophageal cancer is typically evaluated through gastroscopy. In terms of treatment, the approach generally focuses on surgery, potentially supplemented by radiotherapy and chemotherapy.

Other Voices

doctor image
home-news-image
Written by Xu Qing Tian
Otolaryngology
53sec home-news-image

How long does it take for throat cancer to develop?

Throat cancer is a common malignant tumor in otolaryngology, which usually forms over the course of a year or half a year. However, patients typically have long-term chronic stimuli and medical history before the tumor changes occur, such as a long history of smoking or drinking, as well as exposure to physical and chemical factors. Early symptoms of throat cancer often include hoarseness, while in the mid to late stages, patients may experience difficulty swallowing and breathing difficulties. We can make a definite diagnosis through local pathological biopsy, electronic laryngoscopy, and CT scans of the throat area. Early detection of throat cancer should lead to timely surgical treatment, followed by radiotherapy and chemotherapy. For late-stage patients who are not suitable for surgery, chemotherapy or radiotherapy should be administered promptly to extend the patient's lifespan.

doctor image
home-news-image
Written by Li Rui
Otolaryngology
50sec home-news-image

Is throat cancer prone to recurrence?

Throat cancer indeed may recur, but the specific chances and extent of recurrence vary greatly among individuals. Generally speaking, the probability of recurrence is much lower in early-stage throat cancer compared to mid and late stages. For early-stage throat cancer, surgery or radiotherapy is primarily recommended. The first two years are very critical; if there is no recurrence within two years, the likelihood of recurrence is relatively smaller. Then, the next milestone is five years; the five-year survival rate is very significant. If there is no recurrence within five years, it can generally meet the criteria for clinical cure. However, even after five years, a small portion of patients might still experience recurrence, hence the necessity to persist with long-term follow-up examinations.

doctor image
home-news-image
Written by Deng Bang Yu
Otolaryngology
47sec home-news-image

Which area is the most common site for laryngeal cancer?

Laryngeal cancer is a malignant tumor in the larynx, and clinically, it is primarily squamous cell carcinoma. The causes of laryngeal cancer are diverse, with major triggers being the irritation from smoking and alcohol, as well as viral infections. Clinically, laryngeal cancer is categorized into glottic cancer, supraglottic cancer, and subglottic cancer. The most common type is glottic cancer, which occurs on the vocal cords, typically affecting one vocal cord; bilateral occurrence is extremely rare. Glottic cancer, or cancer of the vocal cord area, is often detected early because hoarseness appears as soon as the lesion develops, prompting patients to seek early medical attention. Therefore, when detected early, the treatment outcomes are generally better.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 1sec home-news-image

Does CEA increase in throat cancer?

In the blood tests of some laryngeal cancer patients, an increase in the CEA index may be observed, but most laryngeal cancer patients do not exhibit abnormal CEA levels. This is because laryngeal cancer is a common malignant tumor in the head and neck region, and currently, there are no specific tumor markers clinically for laryngeal cancer. CEA, also known as carcinoembryonic antigen, is a tumor marker that is most often elevated in the bodies of patients with malignant tumors. Clinically, an increase in the CEA level is commonly seen in malignant tumors of the gastrointestinal tract, thoracic malignancies, malignancies in the female urogenital system, and some tumors in the male urogenital system. However, in patients with head and neck malignancies, this marker is not commonly elevated.

doctor image
home-news-image
Written by Xu Qing Tian
Otolaryngology
44sec home-news-image

Can throat cancer patients eat sea cucumber?

Patients with throat cancer can eat sea cucumbers, which contain rich proteins, trace elements, amino acids, and other components that are very beneficial to health. These can help improve the patient's immune function and resist the occurrence of tumors. Additionally, patients should eat more vegetables and fruits containing vitamins to help enhance their immune function. For diagnosing throat cancer, we mainly use electronic nasopharyngoscopy and CT scans of the throat area to make a clear diagnosis. After throat cancer occurs, we usually perform surgery as soon as possible to remove the tumor while trying to preserve as much of the patient's laryngeal function as possible, in order to improve the patient's quality of life.